ROMK potassium channel blocker

oral eff. in hypertension model (1 mpk QD)

backup candidate to MK-7145 (Ph. Ib)

J. Med. Chem., May 26, 2021

Merck & Co., Kenilworth, NJ

MK-8153

The Merck ROMK potassium channel blocker, MK-8153, is a backup development candidate to MK-7145, whose development as a diuretic was terminated after a Ph. Ib study due to lack of…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: